我国独立设置医科大学SCI论文产出对比研究：基于WoS及ESI数据库的分析

目的　通过对国内20所独立设置医科大学的2013至2017年间SCI发文情况分析对比,为国内独立设置医学院校冲刺“一流”高校及“一流”学科建设给出多方面的分析。方法　基于WoS及ESI数据库对近五年这些高校发表的SCI论文相关数据,包括SCI论文产出量、篇均被引次数、高被引论文量、H指数、基金资助情况及来源期刊影响因子等多种文献计量学指标进行数据检索及分析,探索20所高校已发表SCI论文的现状及存在问题。结果　本研究中20所独立设置医科大学均进入ESI数据库,ESI全球排名与US News和ARWU全球排名基本一致;部分院校的临床医学（428名）、药理学与毒物学（94名）已入围或者接近ESI全球1‰排名;高被引论文量与发文量总量的占比仍然低于国内平均水平;H指数与篇均被引成正比,与国内一流高校尚有差距;绝大部分SCI论文获国家级基金项目资助,但文章来源期刊的影响因子不高。结论　我国独立设置医科大学全球排名在近五年飞速上升,虽然与国际一流高校和一流学科尚有差距,但是潜力巨大。临床医学、药理学与毒物学学科发展水平已达国际一流水平,生物与生化、神经科学与行为等为代表的学科发展水平与国际医学水平差距不断缩小。

Comparative study on the output of SCI papers of independent academic medical universities in China: analysis based on WoS and ESI database

Objective To give specific strategies for discipline construction in the "first class" universities and colleges, through the analysis of the SCI service of 20 independent medical universities in China during 2013 to 2017. Methods Based on WoS and ESI database, this paper searches and analyzes the related data of SCI papers published by the above colleges and universities, including the quantity of output, the citation of all articles, the fund support and other bibliometrics indexes, and explores the status and problems of these SCI papers. Results All colleges and universities in this study have entered the ESI database, and the ranking of ESI is basically the same as the global ranking of US News and ARWU; the Clinical Medicine and Pharmacology & Toxicology of some colleges and universities has been in or near the global 1 per thousand of ESI, and the proportion of the quoted volume and the total volume of the document is still lower than the average level in China; the H index is directly proportional to the papers, and there is still a gap with the first-class universities in China. Most papers are funded by national fund projects, but a large number of SCI articles are not highly influential. Conclusion The results show that the global ranking of independent medical universities in China has developed rapidly in the past five years. Although there is still a gap with the international first-class universities and disciplines, but there is great potential. The level of Clinical Medicine and Pharmacology & Toxicology has reached the international first-class level. The gap between the development level of biology and biochemistry, neuroscience and behavior, and the international medical level of these field is narrowing.